Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-06-01
2009-12-22
Epps-Smith, Janet L (Department: 1633)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S007800
Reexamination Certificate
active
07635561
ABSTRACT:
The protein pRb2/p130 represses expression of the ER-α gene. Blocking pRb2/p130 expression or altering ER-α gene methylation to alter pRb2/p130 complex binding allows transcriptional activity of the ER-α gene to be restored. Detecting and regulating the methylation state of the ER-α gene, optionally together with detecting and regulating pRb2/p130 multimolecular complexes bound to the ER-α gene promoter, allows estrogen-insensitive breast cancer cells to be identified, so that an accurate prognosis can be obtained and an appropriate course of treatment administered. Also, inhibiting pRb2/p130, or altering the methylation pattern of the ER-α gene by targeting DNMT 1 In the pRb2/p 130-E2F4/5-HDAC 1-DNMT1-SUV39H1 complex, allows estrogen-insensitive breast cancer cells to be converted to estrogen-sensitive breast cancer cells. Estrogen-sensitive breast cancer cells which are generally more susceptible to current anti-cancer treatments.
REFERENCES:
patent: 2003/0225015 (2003-12-01), Ward et al.
Iwase et al., British Journal of Cancer, 1999, vol. 80, No. 12, pp. 1982-1986.
Macaluso et al., “pRb2/p130-E2F4/5-HDAC1-SUV39H1-P300 and pRb2/p130-E2F4/5-HDACI-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer”, Oncogene, Jun. 2003, vol. 22, pp. 3511-3517.
Iwase et al, “DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers”, British Journal of Cancer, 1999, vol. 80. No. 12, pp. 1982-1986.
Elbashir et al, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, May 2001, vol. 411 pp. 494-498.
Lapidus, et al., “Mapping of ER gene CpG Island Methylation by Methylation-specific Polymerase Chain Reaction,” Cancer Research 58, 2515-2519, Jun. 15, 1998.
Ferguson, et al., “Demethylation of the Estrogen Receptor Gene in Estrogen Receptor-negative Breast Cancer Cells Can Reactivate Estrogen Receptor Gene Expression,” Cancer Research 55, 2279-2283, Jun. 1, 1995.
Yoshida, et al., Distinct Mechanisms of Loss of Estrogen Receptor α Gene Expression in Human Breast Cancer: Methylation of the Gene and Alteration of trans-acting Factors, Carcinogenesis, vol. 21, No. 12, 2193-2201, 2000.
Yan, et al., “Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer,” Journal of Mammary Gland Biology and Neoplasia, vol. 6, No. 2, 183-192, 2001.
Cunningham, et al., Comparison of 5-Azacytidine (NSC-102816) With CCNU (NSC-79037) in the Treatment of Patients With Breast Cancer and Evaluation of the Subsequent Use of Cyclophosphamide (NSC-26271), Cancer Chemotherapy Reports, Part 1, vol. 58, No. 5, 677-681, Sep./Oct. 1974.
Epps-Smith Janet L
McNichol, Jr. William J.
Reed Smith LLP
Temple University of the Commonwealth System of Higher Education
LandOfFree
Methods of diagnosing, prognosing and treating breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of diagnosing, prognosing and treating breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of diagnosing, prognosing and treating breast cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4102784